Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

China’s drug procurement system is under scrutiny as doctors raise alarms over the effectiveness of generic medicines used in ...

Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...

which incentivises the use of cheap generic drugs over original brand-name pharmaceuticals, has led to costs being cut at the expense of people's safety. But officials, quoted by multiple state ...

Invokana is only available as a brand-name drug. It doesn’t come in a generic version. A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics tend to cost ...

DOC, an Italian pharmaceutical company specialized in the marketing of generic drugs, expands its strategy by broadening its business lines and defines a new vision for the future, reflected in a new ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...